Skip to main content
. 2018 Oct 12;97(41):e12826. doi: 10.1097/MD.0000000000012826

Figure 5.

Figure 5

Forest plot for the re-bleeding rate in 5 and 42-day mortality comparing 3 to 5 days’ adjuvant vasoactive drug therapy versus a shorter course. (A) Very early re-bleeding rate; (B) 42-day mortality.